1Armour, KE, Van' T Hof, RJ, Grabowski, PS, Reid, DM & Ralston, SHEvidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. J Bone Miner Res 1999 14, 2137–3142.
2Benzie, FF & Strain, JJThe ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996 239, 70–76.
3Bors, W, Heller, W, Michel, C & Saran, MFlavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods Enzymol 1990 186, 343–355.
4Breuillé, D, Arnal, M, Rambourdin, F, Bayle, G, Levieux, D & Obled, CSustained modifications of protein metabolism in various tissues in a rat model of long-lasting sepsis. Clin Sci (Lond) 1998 94, 413–423.
5Browner, WS, Pressman, AR, Nevitt, MC & Cummings, SRMortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med 1996 156, 1521–1525.
6Chaudiere, JSome chemical and biochemical constraints of oxidative stress in living cells. In Free Radical Damage and its Control, Pp. 25–66 [Rice-Evans, CA and Burdon, RH, editors] New York: Elsevier-Science. 1994.
7Cohen-Solal, ME, Graulet, AM & Denne, MAPeripheral monocyte culture supernatants of menopausal women induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 1993 77, 1648–1653.
8Consensus Development Statement European Foundation for Osteoporosis and the National Osteoporosis Foundation. Who are candidates for prevention and treatment for osteoporosis?. Osteoporosis Int 1997 7, 1–6.
9Cook, JGHFactors influencing the assay of creatinine. Ann Clin Biochem 1975 12, 219–232.
10Cooper, C, Atkinson, EJ, Jacobsen, SJ, O'Fallon, WM & Melton, LJ 3rd Population-based study of survival after osteoporotic fractures. Am J Epidemiol 1993 137, 1001–1005.
11Coxam, V, Bowman, BM, Mecham, M, Roth, CM, Miller, MA & Miller, SCEffects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth and formation rates in ovariectomized rats. Bone 1996 19, 107–114.
12Cuzzocrea, S, Santagati, S, Sautebin, L, Mazzon, E, Calabro, I, Caputi, AP & Maggi, A17 beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology 2000 141, 1455–1463.
13Das, UNInteraction(s) between essential fatty acids, eicosanoids, cytokines, growth factors and free radicals: relevance to new therapeutic strategies in rhumatoid arthritis and other collagen vascular diseases. Prostaglandins Leucot Essent Fatty Acids 1991 44, 201–210.
14Das, UNNitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids. Exp Biol Med 2002 227, 88–93.
15De la Puerta, R, Ruiz Gutierrez, V & Hoult, JRInhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil. Biochem Pharmacol 1999 57, 445–449.
16Diplock, AT, Aggett, P, Ashwell, M, Bornet, F, Fern, EB & Roberfroid, MBScientific concepts of functional foods in Europe: consensus document. Br J Nutr 1999 81, S1–S27.
17Eastell, R, Calvo, MS, Burritt, MF, Offord, KP, Russell, RG & Riggs, BLAbnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis. J Clin Endocrinol Metab 1992 74, 487–494.
18Ershler, WB, Harman, SM & Keller, ETImmunologic aspects of osteoporosis. Dev Comp Immunol 1997 21, 487–499.
19European Commission Report on Osteoporosis in the European Community: Action for Prevention Luxembourg: Office for Official Publication of the European Communities. 1998.
20Fournier, T, Medjoubi, N & Porquet, DAlpha-1-acid glycoprotein. Biochim Biophys Acta 2000 1482, 157–171.
21Horcajada-Molteni, MN & Coxam, VFlavonols and idoflavones prevent bone loss in the ovariectomized rat, a model for postmenopausal osteoporosis. In Nutritional Aspects of Osteoporosis, Pp. 325–340 [Burkhardt, F, Dawson-Hughes, B and Heaney, RP, editors] San Diego: CA Academic Press. 2001.
22Horowitz, MC & Raisz, LGCytokines and Prostaglandins. In Aging Skeleton, Pp. 195–207[Rosen, CJ, Glowack, J and Bilezikian, JP, editors] San Diego: Academic Press. 1999.
23Kalu, DNThe ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991 15, 175–191.
24Kanis, JAThe incidence of hip fracture in Europe. Osteoporos Int 1993 3, 10–15.
25Keys, A, Menotti, A, Karvenen, MJ, Arvanis, C, Blackbuen, H, Buzina, R, Djordjevic, BS, Donsas, AS, Fidanza, F & Keys, MHThe diet and 15-years death rate in the seven countries study. Am J Epidemiol 1986 24, 903–915.
26Martinez-Dominguez, E, De La Puerta, R & Ruiz-Guitiérrez, VProtective effects upon experimental inflammation models of polyphenol-supplemented virgin olive oil diet. Inflamm Res 2001 50, 102–106.
27Martin-Moreno, JM, Willett, WC, Gorgojo, L, Banegas, JR, Rodriguez-Artalejo, F, Fernandez-Rodriguez, JC, Maisonneuve, P & Boyle, PDietary fat, olive oil intake and breast cancer risk. Int J Cancer 1994 58, 774–780.
28Miller, SC, Bowmann, BM, Miller, MA & Bagi, CCalcium absorption and osseous organ, tissue and envelope specific changes following ovariectomy in rats. Bone 1991 12, 439–446.
29Minne, HW, Pfeilschifter, J, Scharla, S, Mutschelknauss, S, Schwarz, A, Krempien, B & Ziegler, RInflammation-mediated osteopenia in the rat: a new animal model for pathological loss of bone mass. Endocrinology 1984 115, 50–54.
30Mody, N, Parhami, F, Sarafian, TA & Demer, LOxidative stress modulates osteoblastic differenciation of vascular and bone cells. Free Radic Biol Med 2001 31, 509–519.
31Ohkawa, H, Ohishi, N & Yagi, KAssay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979 95, 351–358.
32Pacifi, R, Brown, C, Puscheck, E, Slatopolsky, E, Maggio, D, McCracken, R & Avioli, LVEffect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991 88, 5134–5138.
33Quaranta, G & Rotundo, VEconomic and commercial prospects for olive oil in view of the changes in the common market organisation (CMO) (part one). Olivae 2000 91, 20–24.
34Riggs, BL & Melton, LJInvolutional osteoporosis. N Engl J Med 1986 26, 1676–1684.
35Robbins, SPBiochemical markers for assessing skeletal growth. Eur J Clin Nutr 1994 48, S199–S209.
36Tsarbopoulos, A, Gikas, E, Papadopoulos, N, Aligiannis, N & Kafatos, ASimultaneous determination of oleuropein and its metabolites in plasma by high-performance liquid chromatography. J Chromatogr 2003 785, 157–164.
37Tuck, KL, Freeman, MP, Hayball, PJ, Stretch, GL & Stupans, IThe in vivo fate of hydroxytyrosol and tyrosol, antioxidant phenolic constituents of olive oil, after intravenous and oral dosing of labeled compounds to rats. J Nutr 2001 131, 1993–1996.
38Turner, CH & Burr, CBBasic mechanical measurements of bone: a tutorial. Bone 1993 14, 595–608.
39Uebelhart, D, Schlemmer, A, Johansen, J, Gineyts, E, Christiansen, C & Delmas, PDEffects of menopause and hormone therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 1991 72, 367–373.
40Visioli, F, Bellomo, G & Galli, CFree radical-scavenging properties of olive oil polyphenols. Biochem Biophys Res Commun 1998 247, 60–64.
41Vissers, MN, Zock, PL, Roodenburg, AJ, Leenen, R & Katan, MBOlive oil phenols are absorbed in humans. J Nutr 2002 132, 409–417.
42Vukicevic, S, Marusic, A, Stavljenic, A, Cesnjaj, M & Ivankovic, DThe role of tumor necrosis factors-alpha in the generation of acute phase response and bone loss in rats with talc gramulomastosis. Lab Invest 1994 70, 386–391.
43Watkins, BA, Lippman, HE, Bouteiller, LL, Li, Y & Seifert, MFBioactive fatty acids: role in bone biology and bone cell function. Prog Lipid Res 2001 40, 125–148.
44Zeng, SX, Vrindts, Y, Lopez, M, De Groote, D, Zangerle, PF, Collette, J, Franchimont, N, Geenen, V, Albert, A & Reginster, JYIncrease in cytokine production (Il-1 beta, Il-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 1997 26, 63–71.